Loading...
Reduced chromatin binding of MYC is a key effect of HDAC inhibition in MYC amplified medulloblastoma
BACKGROUND: The sensitivity of myelocytomatosis oncogene (MYC) amplified medulloblastoma to class I histone deacetylase (HDAC) inhibition has been shown previously; however, understanding the underlying molecular mechanism is crucial for selection of effective HDAC inhibitors for clinical use. The a...
Na minha lista:
| Udgivet i: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7906057/ https://ncbi.nlm.nih.gov/pubmed/32822486 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa191 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|